Cite
Hernandez JOR, Wang X, Vazquez-Segoviano M, et al. A tissue-bioengineering strategy for modeling rare human kidney diseases in vivo. Nat Commun. 2021;12(1):6496doi: 10.1038/s41467-021-26596-y.
Hernandez, J. O. R., Wang, X., Vazquez-Segoviano, M., Lopez-Marfil, M., Sobral-Reyes, M. F., Moran-Horowich, A., Sundberg, M., Lopez-Cantu, D. O., Probst, C. K., Ruiz-Esparza, G. U., Giannikou, K., Abdi, R., Henske, E. P., Kwiatkowski, D. J., Sahin, M., & Lemos, D. R. (2021). A tissue-bioengineering strategy for modeling rare human kidney diseases in vivo. Nature communications, 12(1), 6496. https://doi.org/10.1038/s41467-021-26596-y
Hernandez, J O R, et al. "A tissue-bioengineering strategy for modeling rare human kidney diseases in vivo." Nature communications vol. 12,1 (2021): 6496. doi: https://doi.org/10.1038/s41467-021-26596-y
Hernandez JOR, Wang X, Vazquez-Segoviano M, Lopez-Marfil M, Sobral-Reyes MF, Moran-Horowich A, Sundberg M, Lopez-Cantu DO, Probst CK, Ruiz-Esparza GU, Giannikou K, Abdi R, Henske EP, Kwiatkowski DJ, Sahin M, Lemos DR. A tissue-bioengineering strategy for modeling rare human kidney diseases in vivo. Nat Commun. 2021 Nov 11;12(1):6496. doi: 10.1038/s41467-021-26596-y. PMID: 34764250; PMCID: PMC8586030.
Copy
Download .nbib